glp-1 receptor antibody Agonists as Treatments for Type 2 Diabetes Structural insight into antibody-mediated antagonism

In their study, four severely obese patients diagnosed with pathogenic heterozygous MC4R variants (2 adults and 2 adolescents) achieved a mean weight reduction of 5.9 kg following 16 weeks of liraglutide treatment, corresponding to a 5.8% reduction from their baseline body weight

it is a structural redesign of the pharmaceutical industry

International Journal of Clinical Practice

From a molecular medicine and cardiovascular research perspective, the mechanistic overlap is particularly compelling, especially considering shared drivers like insulin resistance, systemic inflammation, and lipid dysregulation

How to Choose a Supplement (Without Getting Played) Supplements vary a lot in quality